ABBV(ABBV)
ABBV
Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data
Next report
Oct 30 2026in 23 days
EPS estimate
$3.85
Revenue estimate
$17.31B
EPS beats
11 of last 12
EPS surprise
Each report against the estimate that stood when it landed.
Oct 27 2023Jul 31 2026
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Jul 31 2026 | $3.61 | $3.65 | +1.1% | $16.80B | $16.99B | +1.1% |
| Apr 29 2026 | $2.59 | $2.65 | +2.3% | $14.72B | $15.00B | +1.9% |
| Feb 4 2026 | $2.65 | $2.71 | +2.3% | $16.41B | $16.62B | +1.2% |
| Oct 31 2025 | $1.77 | $1.86 | +5.1% | $15.59B | $15.78B | +1.2% |
| Jul 31 2025 | $2.88 | $2.97 | +3.1% | $15.03B | $15.42B | +2.6% |
| Apr 25 2025 | $2.38 | $2.46 | +3.4% | $12.93B | $13.34B | +3.2% |
| Jan 31 2025 | $2.98 | $2.16 | -27.5% | $14.83B | $15.10B | +1.8% |
| Oct 30 2024 | $2.92 | $3.00 | +2.7% | $14.28B | $14.46B | +1.2% |
| Jul 25 2024 | $2.57 | $2.65 | +3.1% | $14.02B | $14.46B | +3.1% |
| Apr 26 2024 | $2.26 | $2.31 | +2.2% | $11.93B | $12.31B | +3.2% |
| Feb 2 2024 | $2.76 | $2.79 | +1.1% | $12.98B | $14.30B | +10.2% |
| Oct 27 2023 | $2.86 | $2.95 | +3.1% | $13.67B | $13.93B | +1.9% |
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+8.56%
EPS+17.07%
FY2028
Rev+7.42%
EPS+8.68%
FY2029
Rev+5.84%
EPS+11.19%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $67.62B | $73.41B | $78.86B | $83.46B | $85.20B |
| Low | $67.18B | $72.00B | $75.26B | $81.54B | $83.23B |
| High | $68.05B | $75.01B | $81.76B | $84.84B | $86.60B |
| EBITDA Avg | $39.02B | $42.56B | $45.57B | $48.78B | $50.66B |
| Low | $38.80B | $41.09B | $39.83B | $47.51B | $49.32B |
| High | $40.16B | $45.80B | $52.54B | $49.68B | $51.61B |
| EBIT Avg | $32.30B | $36.96B | $40.84B | $44.74B | $47.17B |
| Low | $32.08B | $35.49B | $35.11B | $43.47B | $45.83B |
| High | $33.43B | $40.20B | $47.82B | $45.64B | $48.12B |
| Net Income Avg | $24.82B | $28.72B | $31.98B | $35.24B | $37.27B |
| Low | $24.64B | $27.50B | $27.18B | $34.18B | $36.15B |
| High | $25.78B | $31.44B | $37.82B | $35.99B | $38.07B |
| EPS Avg | $14.04 | $16.44 | $17.86 | $19.86 | $21.01 |
| Low | $13.89 | $15.50 | $15.32 | $19.27 | $20.38 |
| High | $14.53 | $17.72 | $21.32 | $20.29 | $21.46 |
| Analysts (Rev / EPS) | 18 / 9 | 17 / 15 | 19 / 9 | 9 / 3 | 15 / 3 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $18.32B | $16.26B | $18.15B | $18.68B | $19.63B | $18.08B | $19.85B | $19.99B |
| Low | $18.13B | $16.06B | $17.92B | $18.45B | $19.39B | $17.85B | $19.60B | $19.74B |
| High | $18.57B | $16.46B | $18.38B | $18.92B | $19.87B | $18.30B | $20.10B | $20.24B |
| EBITDA Avg | $10.78B | $9.46B | $11.06B | $11.47B | $11.57B | $9.80B | $11.77B | $11.87B |
| Low | $10.48B | $9.35B | $10.92B | $11.32B | $11.42B | $9.68B | $11.62B | $11.71B |
| High | $11.56B | $9.58B | $11.20B | $11.62B | $11.73B | $9.93B | $11.93B | $12.02B |
| EBIT Avg | $9.00B | $7.76B | $9.43B | $9.91B | $10.08B | $8.37B | $10.39B | $10.54B |
| Low | $8.71B | $7.65B | $9.29B | $9.76B | $9.93B | $8.25B | $10.24B | $10.38B |
| High | $9.78B | $7.88B | $9.57B | $10.06B | $10.23B | $8.49B | $10.55B | $10.70B |
| Net Income Avg | $6.93B | $5.89B | $7.29B | $7.69B | $7.83B | $6.40B | $8.09B | $8.21B |
| Low | $6.68B | $5.80B | $7.17B | $7.57B | $7.70B | $6.30B | $7.96B | $8.08B |
| High | $7.58B | $5.99B | $7.40B | $7.81B | $7.96B | $6.50B | $8.22B | $8.35B |
| EPS Avg | $3.91 | $3.33 | $4.11 | $4.34 | $4.42 | $3.61 | $4.57 | $4.64 |
| Low | $3.77 | $3.27 | $4.05 | $4.27 | $4.35 | $3.55 | $4.50 | $4.56 |
| High | $4.28 | $3.38 | $4.18 | $4.41 | $4.49 | $3.67 | $4.64 | $4.71 |
| Analysts (Rev / EPS) | 11 / 10 | 5 / 8 | 5 / 8 | 8 / 8 | 5 / 8 | 4 / 9 | 5 / 9 | 8 / 9 |
AI Earnings SummaryQ2 2026
Checking for summary...
Explore More
Healthcare Stocks
More Healthcare stocks
ABBV vs AMGN
Compare ABBV and AMGN side by side
ABBV vs BMY
Compare ABBV and BMY side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers
